213 related articles for article (PubMed ID: 32629696)
1. Volatile organic compounds analysis as a potential novel screening tool for colorectal cancer: A systematic review and meta-analysis.
Zhou W; Tao J; Li J; Tao S
Medicine (Baltimore); 2020 Jul; 99(27):e20937. PubMed ID: 32629696
[TBL] [Abstract][Full Text] [Related]
2. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
[TBL] [Abstract][Full Text] [Related]
3. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of volatile organic compounds analysis and electronic noses for detecting colorectal cancer: a systematic review and meta-analysis.
Wang Q; Fang Y; Tan S; Li Z; Zheng R; Ren Y; Jiang Y; Huang X
Front Oncol; 2024; 14():1397259. PubMed ID: 38817891
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
Sun G; Meng J; Duan H; Zhang D; Tang Y
Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.
Hanna GB; Boshier PR; Markar SR; Romano A
JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487
[TBL] [Abstract][Full Text] [Related]
7. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
Wang C; Zhao K; Rong Q
Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
[TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer.
Chandrapalan S; Bosch S; Cubiella J; Guardiola J; Kimani P; Mulder C; Persaud K; de Meij TGJ; Altomare DF; Brenner H; de Boer NKH; Ricciardiello L; Arasaradnam RP
Aliment Pharmacol Ther; 2021 Jul; 54(1):14-23. PubMed ID: 34004036
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis.
Jin WJ; Xu JM; Xu WL; Gu DH; Li PW
World J Gastroenterol; 2014 Nov; 20(43):16334-42. PubMed ID: 25473192
[TBL] [Abstract][Full Text] [Related]
11. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
[TBL] [Abstract][Full Text] [Related]
12. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
Di Lena M; Porcelli F; Altomare DF
Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of circular RNAs in colorectal cancer: A systematic review and meta-analysis.
Zhao Z; Zhao Y; Liu Y; Zou J; Zhu Y
Pathol Res Pract; 2019 Dec; 215(12):152680. PubMed ID: 31635986
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of magnifying chromoendoscopy in the assessment of tumor invasion depth in early colorectal cancer: a systematic review and meta-analysis.
Huang Y; Yang Z; Yao Y; Liu G; Chen R
Tech Coloproctol; 2023 Dec; 27(12):1155-1167. PubMed ID: 37474693
[TBL] [Abstract][Full Text] [Related]
15. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
[TBL] [Abstract][Full Text] [Related]
16. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
[TBL] [Abstract][Full Text] [Related]
18. Predictive power of circulating miRNAs in detecting colorectal cancer.
Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
[TBL] [Abstract][Full Text] [Related]
19. Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis.
Zhou XJ; Dong ZG; Yang YM; Du LT; Zhang X; Wang CX
Asian Pac J Cancer Prev; 2013; 14(8):4699-704. PubMed ID: 24083729
[TBL] [Abstract][Full Text] [Related]
20. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
